| Ticker Symbol: | CYBX |
|---|---|
| Exchange: | NASD |
| Contact Info: | 100 Cyberonics Blvd Houston TX 77058-2072 281 228-7200 |
| CEO/President: | Daniel J. Moore |
| Industry: | Medical Instruments / Standard Industry Code: 3845 |
| Description: | Cyberonics, Inc. was founded to design, develop and market medical devices for the treatment of epilepsy and other debilitating neurological disorders using a therapy, vagus nerve stimulation. The company's initial target market is epilepsy, the world's second most prevalent neurological disorder, which is characterized by seizures. Vagus nerve stimulation with the Cyberonics NCP System was approved for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents with medically refractory partial onset seizures. (PRESS RELEASE) |
| Shares Outstanding: | 26,940 (000) | Market Value: | 295,290 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 94.70% | Number of Inst.Shareholders: | 10.30% |
| Last Quarter Sales: | 33.73 ($Mil.) | Last Quarter Net Income: | 2.05 ($Mil.) |
| Last Quarter EPS: | 0.08 | P/E Ratio: | 0 |
| Most Recent Earnings: | 0.08 on 08/21/08 | Earnings Per Share: | 0.00 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| HOLOGIC INC | -59.10 | 14.14 | |
| VARIAN MED SYS | -15.50 | 40.69 | |
| MINDRAY MEDICAL | -60.00 | 18.31 | |
| AMAG PHARMACEUT | -52.00 | 35.46 | |
| THORATEC CORP | +21.10 | 23.08 |
